Are you Dr. Cleary?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
44 Binney St
Danafarber Cancer Institute
Boston, MA 02115Phone+1 617-632-3000Fax+1 617-632-5370
Summary
- Dr. James Cleary, MD is an oncologist in Boston, Massachusetts. He is currently licensed to practice medicine in Massachusetts, New Hampshire, and Connecticut. He is an Instructor in Medicine at Dana-Farber Cancer Institute.
Certifications & Licensure
FL State Medical License 2022 - Present
MA State Medical License 2005 - 2026
OH State Medical License 2022 - 2026
RI State Medical License 2022 - 2026
VT State Medical License 2022 - 2026
CT State Medical License 2022 - 2025
ME State Medical License 2022 - 2025
American Board of Internal Medicine Medical Oncology- Join now to see all
Publications & Presentations
PubMed
- CITRINO: phase 1 dose escalation study of anti-LAG-3 antibody encelimab alone or in combination with anti-PD-1 dostarlimab in patients with advanced/metastatic solid t...J Randolph Hecht, Jean-Marie Michot, David Bajor, Amita Patnaik, Ki Y Chung
BJC Reports. 2025-02-27 - Efficacy of Zenocutuzumab inFusion-Positive Cancer.Alison M Schram, Koichi Goto, Dong-Wan Kim, Teresa Macarulla, Antoine Hollebecque
The New England Journal of Medicine. 2025-02-06 - A Phase I Trial of Trebananib, an Angiopoietin 1 and 2 Neutralizing Peptibody, Combined with Pembrolizumab in Patients with Advanced Ovarian and Colorectal Cancer.Brandon M Huffman, Osama E Rahma, Kevin Tyan, Yvonne Y Li, Anita Giobbie-Hurder
Cancer Immunology Research. 2025-01-09
Press Mentions
Novobiocin Attacks BRCA-Mutated Cancer Cells from Within and Without, Study ShowsMarch 14th, 2023
The Pancreatic Cancer Collective Awards $7 Million in First-Round “New Therapies Challenge” GrantsNovember 20th, 2018
Doctors Hail New Approach in Pancreatic Cancer TreatmentSeptember 12th, 2018
